Stock and Flow of Peritoneal Dialysis Patients Australia

Slides:



Advertisements
Similar presentations
ANZDATA Registry Annual Report 2013 STOCK AND FLOW CHAPTER 1.
Advertisements

The Importance of Residual Renal Function Dr Paul Tam June 11, 2010.
End Stage Kidney Disease Treatment Modalities Australia New Zealand Dec 2012 Prepared by Debbie Fortnum Kidney Health Australia Data courtesy of ANZDATA.
Peritoneal Dialysis Adequacy & Prescription Management
HAEMODIALYSIS CHAPTER 5. © ANZDATA Registry Figure 5.1 Stock and Flow of Haemodialysis Patients Australia Patients new.
Nancy Briggs Kylie Hurst Stephen McDonald CHAPTER 4 METHOD AND LOCATION OF DIALYSIS 2012 Annual Report—35th Edition ANZDATA Registry Annual Report 2012.
Anatomy and Physiology of Peritoneal Dialysis
© ANZDATA Registry TRANSPLANTATION CHAPTER 5. © ANZDATA Registry Figure 8.1 Number of Kidney Transplant Operations Total (Living Donors) Year Australia.
CHAPTER 12 Peritoneal Dialysis Sunita Bavanandan Lily Mushahar Anita Bhajan Manocha Source: 20 th MDTR Report 2012, NRR.
© ANZDATA Registry Method and Location of Dialysis 1453 (30%) 632 (13%) 1317 (27%) 1335 (27%) Number of Patients Australia 31-Dec-96.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PERITONEAL DIALYSIS CHAPTER 6.
Kevan Polkinghorne Aarti Gulyani Stephen McDonald Kylie Hurst CHAPTER 5 HAEMODIALYSIS (including home haemodialysis) 2012 Annual Report—35th Edition ANZDATA.
© ANZDATA Registry PEADIATRIC CHAPTER CHAPTER 11.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PAEDIATRIC CHAPTER 11.
ANZDATA Registry Overview Dr Graeme Russ Darwin September 2001 September 2001.
CHAPTER 1: ALL RENAL REPLACEMENT THERAPY IN MALAYSIA Lim Yam Ngo Ong Loke Meng Goh Bak Leong Lee Day Guat Source: 20 th MDTR Report 2012, NRR.
© ANZDATA Registry Method and Location of Dialysis (31%) 634 (12%) 1396 (26%) 1523 (28%) Number of Patients Australia 30-Sep-98 METHA.BRIS98.
Chapter 5 Peritoneal Dialysis 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Peritoneal.
Chapter 12 End Stage Kidney Disease among Indigenous Peoples of Australia and New Zealand 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
Chapter 6 Home Dialysis 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
© ANZDATA Registry Prevalence and Incidence End Stage Renal Failure - Australia ( ) Per Million Functioning Transplant (259) New Pts (82) Deaths.
DEATHS CHAPTER 3. © ANZDATA Registry Figure 3.1 Survival among People who Commenced Dialysis 2001—2010 (Non-Indigenous) % (95% CI) Age at Start Time Period.
STOCK AND FLOW CHAPTER 1. © ANZDATA Registry Figure 1.1 Prevalent Patients (Number Per Million Population at 31st December)
Blair Grace Kylie Hurst Stephen McDonald CHAPTER 1 STOCK AND FLOW 2012 Annual Report—35th Edition ANZDATA Registry Annual Report 2012.
© ANZDATA Registry Stock and Flow of CAPD Patients Australia Number of Patients 1504 Patients * (Data to 30 Sept) Extrapolated.
Chapter 1 ALL RENAL REPLACEMENT THERAPY IN MALAYSIA
END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND CHAPTER 12.
CHAPTER 2 DIALYSIS IN MALAYSIA Goh Bak Leong Lim Yam Ngo Ong Loke Meng Ghazali Ahmad Lee Day Guat Source: 20 th MDTR Report 2012, NRR.
Volume 59, Issue 2, Pages (February 2001)
First-year death rates by modality figure 8
West Midlands Renal Peer Review
Prevalence (pmp) of Renal Replacement Therapy
The ADEMEX Trial Adequacy of PD in Mexico Reference
December 31st point prevalent counts by modality figure 3.1
The CANUSA Trial Reference
CHAPTER 6 PERITONEAL DIALYSIS Fiona Brown Aarti Gulyani
2013 Annual Report - 36th Edition
CHAPTER 5 Paediatric Renal Replacement Therapy
CHAPTER 11: Haemodialysis Practices
Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.
METHOD AND LOCATION OF DIALYSIS CHAPTER 4.
Volume 64, Pages S3-S12 (December 2003)
ANZDATA Registry Annual Report 2013
CHAPTER 1 All Renal Replacement Therapy In Malaysia
CHAPTER 3 DEATHS Stephen McDonald 2012 Annual Report—35th Edition
Volume 78, Issue 6, Pages (September 2010)
Cause Specific Death Rates for All Dialysis Patients
2013 Annual Report - 36th Edition
Table 6.1.1: Stock and Flow, *based on year of death Year
Peritoneal dialysis adequacy and risk of death
ANZDATA Registry 41st Annual Report Highlights of End Stage Kidney Disease in Australia and New Zealand Data to 31-Dec-2017.
American Journal of Kidney Diseases
Scatterplots showing the association between the three peritoneal equilibration test (PET) parameters. Scatterplots showing the association between the.
Adult peritoneal dialysis patients
UK Renal Registry 10th Annual Report 2007
American Journal of Kidney Diseases
Volume 59, Issue 2, Pages (February 2001)
Mary B. Leonard, Lynn A. Donaldson, Martin Ho, Denis F. Geary 
Dialysis outcomes in Australia & New Zealand
Among three residual kidney function (RKF) indices, only residual urine volume (UV) indicated an independent prognostic value in patients with UV≥0.1 or.
Number of Donors in Australia
ANZDATA Peritoneal Dialysis Report
Stock and Flow of Haemodialysis Patients Australia
Prevalent Dialysis and Transplants Australia (at 31st December) Number of Patients
Stock and Flow of Peritoneal Dialysis Patients Australia
Stock and Flow of Peritoneal Dialysis Patients Australia
Stock and Flow of Peritoneal Dialysis Patients Australia
Stock and Flow of Haemodialysis Patients Australia
Australia and New Zealand
Australia and New Zealand
Presentation transcript:

Stock and Flow of Peritoneal Dialysis Patients Australia 1999 - 2003 Number of Patients New Patients Transplants Perm. Transfer Deaths No. Dialysing 1823 Patients 1999 2000 2001 2002 2003

Stock and Flow of Peritoneal Dialysis Patients New Zealand 1999 - 2003 Number of Patients New Patients Transplants Perm. Transfer Deaths No. Dialysing 769 Patients 1999 2000 2001 2002 2003

Age of New PD Patients 2003 Australia No. Pats. 20 21 52 84 110 153 215 134 5

Age of Dialysing PD Patients 31-Dec-2003 Australia No. Pats. 25 36 93 185 264 366 525 315 14

PD Patients (%) of all Prevalent Dialysis Australia 31-Dec-2003

Number (Per Million) Prevalent PD Patients Australia 1999 - 2003

Number of Prevalent APD/CAPD Patients Australia 1999 - 2003 % APD 4.4% 6.1% 7.3% 8.4% 9.5%

Number (Per Million) Prevalent APD Patients Australia 1999 - 2003

PD Patients (%) of all Prevalent Dialysis New Zealand 31-Dec-2003

Number (Per Million) Prevalent PD Patients New Zealand 1999 - 2003

Number of Prevalent APD/CAPD Patients New Zealand 1999 - 2003 % APD 4.2% 6.1% 7.6% 8.5% 8.9%

Number (Per Million) Prevalent APD Patients New Zealand 1999 - 2003

Age of New PD Patients 2003 New Zealand No. Pats. 7 11 10 26 45 68 67 23 3

Age of Dialysing PD Patients New Zealand 31-Dec-2003 No. Pats. 7 29 46 70 133 208 186 83 7

First PD Treatment to First Peritonitis Related to Age at Entry 1999 - 2003 % Survival Australia Age Group

First PD Treatment to First Peritonitis Related to Age at Entry 1999 - 2003 % Survival New Zealand Age Group

First PD Treatment to First Peritonitis Related to Race Australia 1994-1998 Caucasoid 35-54 yrs 55-64 yrs 35-54 yrs 55-64 yrs Aboriginal/Torres St Maori/Pac Isl

First PD Treatment to First Peritonitis Related to Race Australia 1999-2003 Caucasoid 35-54 yrs 55-64 yrs 55-64 yrs 35-54 yrs Aboriginal/Torres St Maori/Pac Isl

First PD Treatment to First Peritonitis Related to Race New Zealand 1994-1998 Caucasoid 35-54 yrs 55-64 yrs Maori/Pac Isl 35-54 yrs 55-64 yrs

First PD Treatment to First Peritonitis Related to Race New Zealand 1999-2003 Caucasoid 35-54 yrs 55-64 yrs Maori/Pac Isl 55-64 yrs 35-54 yrs

Relationship of Residual GFR to Kt/V March 2004 Residual GFR Dialysate 95% C.I Kt/V <= 1 ml / min (n=341) 2.09 (1.21 – 2.97) Aust > 1 ml / min (n=918) 1.98 (0.73 – 3.23) <= 1 ml / min (n=158) 2.08 (1.2 – 2.96) NZ > 1 ml / min (n=395) 1.73 (0.65 – 2.81)

Kt/V Related to Volume of Dialysate Australia March 2004 Prescribed Achieved Kt/V (Total) Dialysate Volume <= 1.8 > 1.8 <= 56 L / week 220 (44%) 282 (56%) >= 70 L / week 241 (33%) 480 (67%) 461 762

Kt/V Related to Volume of Dialysate New Zealand March 2004 Prescribed Achieved Kt/V (Total) Dialysate Volume <= 1.8 > 1.8 <= 56 L / week 152 (68%) 72 (32%) >= 70 L / week 150 (40%) 228 (60%) 302 300

PET D/P Creatinine at Four Hours New PD Patients from 1-Apr-99 to 31-Mar-04

Peritoneal Transport Status New PD Patients 1-Apr-1999 to 31-Mar-2004

p <0.01

p=n.s.

Primary Organism for all Peritonitis Episodes Australia 1-Oct-2003 to 31-Mar-2004

Initial Antibiotic Regimens by State 1-Oct-2003 to 31-Mar-2004 Percentage